drugset

drugset / Trial / NCT06853522

hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

NCT06853522 ↗

Phase 0 Not yet recruiting 40 enrolled Shanghai East Hospital

RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the safety and efficacy of hUC-MSCs-Exos in the treatment of ulcerative colitis.

Timeline

Start: 2025-05-30
Primary completion: 2027-04-04
Completion: 2028-04-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	hUC-MSCs-Exos	Unknown	—	—

Indications